NextCure, Inc.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
NextCure, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing immunomedicines for cancer and other immune-related diseases. The company’s work centers on identifying biological pathways, biomarkers, and immune-cell interactions within the tumor microenvironment to create therapies for patients whose cancers do not respond well to current treatments. Its current programs emphasize targeted approaches such as antibody-drug conjugates and other differentiated mechanisms of action designed to address difficult-to-treat tumors. NextCure also uses its FIND-IO discovery platform to help identify novel immune targets and support pipeline development. Headquartered in Beltsville, Maryland, NextCure plays a specialized role in the oncology and immunology markets by advancing experimental therapies intended to improve treatment options for patients with limited alternatives.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Michael S. Richman MSBA
- Employees
- 40
- Headquarters
- Beltsville, MD, United States
- Website
- www.nextcure.com